Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of G-CSF and autologous cord blood infusion in children with cerebral palsy
KCT0002512Phase 2Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- May 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of filgrastim in cerebral palsy (CP), sponsored by Ministry of Health & Welfare. Started May 2016; status: recruiting.
02
Drugs
filgrastim
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on KCT0002512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002512.